Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2551222rdf:typepubmed:Citationlld:pubmed
pubmed-article:2551222lifeskim:mentionsumls-concept:C0013216lld:lifeskim
pubmed-article:2551222lifeskim:mentionsumls-concept:C2239176lld:lifeskim
pubmed-article:2551222lifeskim:mentionsumls-concept:C1134564lld:lifeskim
pubmed-article:2551222pubmed:issue8 Pt 2lld:pubmed
pubmed-article:2551222pubmed:dateCreated1989-10-23lld:pubmed
pubmed-article:2551222pubmed:abstractTextIn 24 cases of unresectable hepatocellular carcinoma, we performed hepatic arterial catheterization and intra-arterial infusion chemotherapy. Adriamycin (ADM), Mitomycin C (MMC), 5-FU and Lipiodol (LPD) were administered an average of 13.5 times over a mean period of 106 days. Except for 5 unevaluable cases, there were 0 CR, 5 PR, 4 MR, 7 NC and 2 PD cases, for an efficiency rate of 27.8%. Complications thought to be due to the catheter included catheter blockade in 1 case (4.3%) and dermal infection of insertion site in 3 cases (13.0%). As for the results of follow-up study, one-year survival rate with this therapy was 47.8%, which compares favorably with a one-year survival rate of 30.0% in 30 cases treated only with TAE. From the above results, hepatic arterial infusion chemotherapy can be repeatedly performed on an outpatient basis, and it is considered to be a useful therapeutic method for treating unresectable hepatocellular carcinoma.lld:pubmed
pubmed-article:2551222pubmed:languagejpnlld:pubmed
pubmed-article:2551222pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2551222pubmed:citationSubsetIMlld:pubmed
pubmed-article:2551222pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2551222pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2551222pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2551222pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2551222pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2551222pubmed:statusMEDLINElld:pubmed
pubmed-article:2551222pubmed:monthAuglld:pubmed
pubmed-article:2551222pubmed:issn0385-0684lld:pubmed
pubmed-article:2551222pubmed:authorpubmed-author:MoritaSSlld:pubmed
pubmed-article:2551222pubmed:authorpubmed-author:IsozakiHHlld:pubmed
pubmed-article:2551222pubmed:authorpubmed-author:OkajimaKKlld:pubmed
pubmed-article:2551222pubmed:authorpubmed-author:IshibashiTTlld:pubmed
pubmed-article:2551222pubmed:authorpubmed-author:TanimuraMMlld:pubmed
pubmed-article:2551222pubmed:authorpubmed-author:HaraHHlld:pubmed
pubmed-article:2551222pubmed:authorpubmed-author:NishimuraJJlld:pubmed
pubmed-article:2551222pubmed:authorpubmed-author:NakataEElld:pubmed
pubmed-article:2551222pubmed:authorpubmed-author:AmiokaKKlld:pubmed
pubmed-article:2551222pubmed:authorpubmed-author:IgaCClld:pubmed
pubmed-article:2551222pubmed:issnTypePrintlld:pubmed
pubmed-article:2551222pubmed:volume16lld:pubmed
pubmed-article:2551222pubmed:ownerNLMlld:pubmed
pubmed-article:2551222pubmed:authorsCompleteYlld:pubmed
pubmed-article:2551222pubmed:pagination2778-81lld:pubmed
pubmed-article:2551222pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2551222pubmed:meshHeadingpubmed-meshheading:2551222-...lld:pubmed
pubmed-article:2551222pubmed:meshHeadingpubmed-meshheading:2551222-...lld:pubmed
pubmed-article:2551222pubmed:meshHeadingpubmed-meshheading:2551222-...lld:pubmed
pubmed-article:2551222pubmed:meshHeadingpubmed-meshheading:2551222-...lld:pubmed
pubmed-article:2551222pubmed:meshHeadingpubmed-meshheading:2551222-...lld:pubmed
pubmed-article:2551222pubmed:meshHeadingpubmed-meshheading:2551222-...lld:pubmed
pubmed-article:2551222pubmed:meshHeadingpubmed-meshheading:2551222-...lld:pubmed
pubmed-article:2551222pubmed:meshHeadingpubmed-meshheading:2551222-...lld:pubmed
pubmed-article:2551222pubmed:meshHeadingpubmed-meshheading:2551222-...lld:pubmed
pubmed-article:2551222pubmed:meshHeadingpubmed-meshheading:2551222-...lld:pubmed
pubmed-article:2551222pubmed:meshHeadingpubmed-meshheading:2551222-...lld:pubmed
pubmed-article:2551222pubmed:meshHeadingpubmed-meshheading:2551222-...lld:pubmed
pubmed-article:2551222pubmed:meshHeadingpubmed-meshheading:2551222-...lld:pubmed
pubmed-article:2551222pubmed:meshHeadingpubmed-meshheading:2551222-...lld:pubmed
pubmed-article:2551222pubmed:meshHeadingpubmed-meshheading:2551222-...lld:pubmed
pubmed-article:2551222pubmed:meshHeadingpubmed-meshheading:2551222-...lld:pubmed
pubmed-article:2551222pubmed:meshHeadingpubmed-meshheading:2551222-...lld:pubmed
pubmed-article:2551222pubmed:year1989lld:pubmed
pubmed-article:2551222pubmed:articleTitle[Hepatic arterial infusion chemotherapy of hepatocellular carcinoma].lld:pubmed
pubmed-article:2551222pubmed:affiliationDept. of General and Gastrointestinal Surgery, Osaka Medical College.lld:pubmed
pubmed-article:2551222pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2551222pubmed:publicationTypeEnglish Abstractlld:pubmed